Skip to main navigation Skip to search Skip to main content

Nebulised heparin as a treatment for COVID-19: Scientific rationale and a call for randomised evidence

  • Frank M.P. Van Haren*
  • , Clive Page
  • , John G. Laffey
  • , Antonio Artigas
  • , Marta Camprubi-Rimblas
  • , Quentin Nunes
  • , Roger Smith
  • , Janis Shute
  • , Mary Carroll
  • , Julia Tree
  • , Miles Carroll
  • , Dave Singh
  • , Tom Wilkinson
  • , Barry Dixon
    • *Corresponding author for this work

    Research output: Contribution to journal › Review article › peer-review

    94 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Nebulised heparin as a treatment for COVID-19: Scientific rationale and a call for randomised evidence'. Together they form a unique fingerprint.
    Sort by

    Medicine and Dentistry

    Immunology and Microbiology

    Pharmacology, Toxicology and Pharmaceutical Science